Onyx Pharmaceuticals, Inc. Stock
Equities
US6833991093
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2013 | Gilead Sciences, Inc. : Bradway's patient dealmaking brings Onyx to Amgen | RE |
2013 | Onyx Pharmaceuticals, Inc. : Onyx deal expected to give Amgen a big boost | RE |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.38% | 21.25B | |
-5.80% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |
- Stock Market
- Equities
- Stock